George Poste
pathologist
Pediatric
Haplogen
Austria
Biography
Dr. Poste trained in veterinary medicine (University of Bristol), holds several additional doctorates and is a board-certified pathologist. He was elected a Fellow of the Royal Society in 1997. From 1992 to 1999, he was CSO and CTO of SmithKline Beecham (now GSK) where he oversaw the registration of 31 drug, vaccine and diagnostic products. Currently, he’s the Director of the Complex Adaptive Systems Institute at Arizona State University. He serves on the Board of Directors for Monsanto; Exelixis and Caris Life Sciences and the Scientific Advisory Board for Synthetic Genomics. Dr. Poste trained in veterinary medicine (University of Bristol), holds several additional doctorates and is a board-certified pathologist. He was elected a Fellow of the Royal Society in 1997. From 1992 to 1999, he was CSO and CTO of SmithKline Beecham (now GSK) where he oversaw the registration of 31 drug, vaccine and diagnostic products. Currently, he’s the Director of the Complex Adaptive Systems Institute at Arizona State University. He serves on the Board of Directors for Monsanto; Exelixis and Caris Life Sciences and the Scientific Advisory Board for Synthetic Genomics.
Research Interest
Pediatric Cardiology, Pediatric Neurology & Diseases, Pediatric & Neonatal Care
